Fisher Asset Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-95,778
Closed -$2.64M 1037
2023
Q4
$2.64M Sell
95,778
-6,359
-6% -$175K ﹤0.01% 558
2023
Q3
$2.29M Sell
102,137
-51,165
-33% -$1.15M ﹤0.01% 609
2023
Q2
$6.23M Sell
153,302
-3,818
-2% -$155K ﹤0.01% 517
2023
Q1
$7.61M Sell
157,120
-43,757
-22% -$2.12M ﹤0.01% 489
2022
Q4
$7.67M Sell
200,877
-3,511
-2% -$134K 0.01% 486
2022
Q3
$10.3M Sell
204,388
-22,909
-10% -$1.15M 0.01% 397
2022
Q2
$9.11M Buy
227,297
+12,323
+6% +$494K 0.01% 365
2022
Q1
$8.02M Buy
214,974
+11,000
+5% +$410K ﹤0.01% 399
2021
Q4
$8.12M Buy
203,974
+27,818
+16% +$1.11M ﹤0.01% 410
2021
Q3
$6.56M Buy
176,156
+15,671
+10% +$583K ﹤0.01% 398
2021
Q2
$6.78M Buy
160,485
+4,097
+3% +$173K ﹤0.01% 398
2021
Q1
$7.41M Buy
156,388
+6,282
+4% +$297K 0.01% 392
2020
Q4
$9.16M Sell
150,106
-14,142
-9% -$863K 0.01% 365
2020
Q3
$7.68M Sell
164,248
-19,567
-11% -$915K 0.01% 356
2020
Q2
$9.33M Sell
183,815
-6,671
-4% -$338K 0.01% 339
2020
Q1
$8.5M Sell
190,486
-35,324
-16% -$1.58M 0.01% 316
2019
Q4
$10.8M Sell
225,810
-41,813
-16% -$2.01M 0.01% 337
2019
Q3
$9.05M Sell
267,623
-105
-0% -$3.55K 0.01% 373
2019
Q2
$12M Buy
267,728
+135,289
+102% +$6.09M 0.01% 345
2019
Q1
$4.99M Hold
132,439
0.01% 415
2018
Q4
$4.55M Sell
132,439
-1,357
-1% -$46.6K 0.01% 423
2018
Q3
$6.29M Sell
133,796
-15,104
-10% -$710K 0.01% 396
2018
Q2
$5.02M Sell
148,900
-8,935
-6% -$301K 0.01% 432
2018
Q1
$4.27M Sell
157,835
-7,823
-5% -$212K 0.01% 446
2017
Q4
$2.76M Sell
165,658
-7,387
-4% -$123K ﹤0.01% 494
2017
Q3
$3.46M Buy
173,045
+83,403
+93% +$1.67M ﹤0.01% 440
2017
Q2
$1.64M Hold
89,642
﹤0.01% 497
2017
Q1
$882K Buy
89,642
+1,800
+2% +$17.7K ﹤0.01% 515
2016
Q4
$958K Sell
87,842
-1,800
-2% -$19.6K ﹤0.01% 512
2016
Q3
$1.26M Hold
89,642
﹤0.01% 503
2016
Q2
$670K Buy
89,642
+3,942
+5% +$29.5K ﹤0.01% 538
2016
Q1
$764K Buy
+85,700
New +$764K ﹤0.01% 535